patient access
patient access
Unlocking Biopharma: WuXi’s PAT Revolution!
BIOT
🌟 WuXi Biologics champions PAT in BioPharma, enhancing control and quality assurance for rapid therapy development! 📊🔬💡 BiotechInnovation
Unlocking Faster Treatments: Hospital CGT Production Revealed
BIOT
🏥 Hospital-based CGT production enhances patient access, reduces timelines, and ensures quality. Collaboration can lower costs and improve outcomes! 🔬⏳🤝
Breaking: CGTs Accessibility Challenges Uncovered in 2023
BIOT
📰CGTs in 2023: Floodgates open but patient access still sticky highlights challenges in patient access to CGTs. 👥💡💰⚕️🤝🌍
